This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hospital of Stomatology, Guangzhou Medical University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of XI Xiang in Osteogenic Differentiation
Introduction
XI Xiang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of dental medicine, particularly in promoting osteogenic differentiation of dental mesenchymal stem cells. His work has the potential to impact bone tissue regeneration, which is crucial for various dental and medical applications.
Latest Patents
XI Xiang holds a patent for the use of G007-LK in promoting osteogenic differentiation of dental mesenchymal stem cells and bone tissue regeneration. The patent discloses that G007-LK can induce SHED (Stem Cells from Human Exfoliated Deciduous teeth) to form mineralized nodules and promote osteogenic differentiation. In vitro experiments demonstrate that G007-LK has the ability to enhance the osteogenic effect of SHED. Furthermore, in vivo experiments indicate that G007-LK pretreatment of SHED for seven days, combined with Geistlich Bio-Oss® collagen bone scaffold, can significantly promote subcutaneous ectopic osteogenesis in nude mice. This suggests that G007-LK possesses good osteoinductivity and could serve as a potential osteogenic drug.
Career Highlights
XI Xiang is affiliated with the Hospital of Stomatology at Guangzhou Medical University. His research focuses on the intersection of dental medicine and regenerative therapies, showcasing his commitment to advancing the field. His innovative approach to utilizing G007-LK highlights his dedication to improving patient outcomes in dental treatments.
Collaborations
XI Xiang collaborates with notable colleagues, including Keyu Lyu and Danyuan Xie. Their combined expertise contributes to the advancement of research in dental stem cell applications and regenerative medicine.
Conclusion
XI Xiang's work in promoting osteogenic differentiation through G007-LK represents a significant advancement in dental medicine. His contributions have the potential to enhance bone tissue regeneration, paving the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile